Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,938,345
in 7 filings, $1.9M under 10b5-1 plans

Net −$1,938,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-08 Rothenberg Mace Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-06-08 Huber Reid M Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-02-01 Weber Barbara Chief Executive Officer Grant or award · Stock Option (Right to Buy) +625,000 625,000
2022-02-01 Barry Douglas General Counsel Grant or award · Stock Option (Right to Buy) +69,500 69,500
2022-02-01 Beckman Daniella Chief Financial Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2022-02-01 Huang Alan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2021-11-01 Rudoltz Marc Chief Medical Officer Grant or award · Stock Option (Right to Buy) +350,000 350,000
2021-08-12 Weber Barbara Chief Executive Officer Grant or award · Stock Option (Right to Buy) +961,403 961,403
2021-08-12 Huang Alan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +169,859 169,859
2021-08-12 Beckman Daniella Chief Financial Officer Grant or award · Stock Option (Right to Buy) +380,485 380,485
2020-11-20 BCTG Holdings, LLC 10% owner Sale −2,500 $0.01 $15 4,490,950
2020-11-20 BCTG Holdings, LLC 10% owner Sale −2,500 $0.01 $15 4,488,450
2020-09-08 BCTG Holdings, LLC 10% owner Purchase +533,500 $10.00 $5.3M 4,493,450

Page 12 of 12 · 233 trades